EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In silico identification of Leishmania GP63 protein epitopes to generate a new vaccine antigen against leishmaniasis

Mervenur Güvendi, Hüseyin Can iD, İrem Yavuz, Ahmet Özbilgin, Aysu Değirmenci Döşkaya, Muhammet Karakavuk, Cemal Ün, Adnan Yüksel Gürüz, İsmail Cem Yılmaz, Mayda Gürsel, İhsan Gürsel, Mert Döşkaya

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0013137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Mervenur Güvendi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology Molecular Biology Section, Faculty of Science, Ege University, İzmir, Türkiye. Hauptthemen laut MEDLINE: Antigens, Protozoan, Metalloendopeptidases, Leishmaniasis Vaccines, Leishmaniasis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Scientific and Technological Research Council of Türkiye, Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background The surface of Leishmania spp. presents glycoprotein 63 (GP63), a metalloprotease that acts as one of the parasite’s major antigens. A vaccine against leishmaniasis has not yet been developed and stationary phase promastigotes have utmost importance in transmitting Leishmania spp. from phlebotomine sand fly to humans or reservoirs. Therefore, this study aimed to analyze GP63 protein in three different Leishmania spp. to determine new vaccine candidate antigen against leishmaniasis using sequencing data of locally detected Leishmania strains and in silico approaches. Methodology/Principal findings The GP63 protein sequences of the stationary phase/amastigote form of L. infantum , L. major , and L. tropica were identified and then the gene encoding GP63 protein in Leishmania positive samples (n:59) was amplified and sequenced for variation analysis. According to the results, 4, 6, 19 GP63 variants were found within L. infantum , L. major , and L. tropica isolates, respectively. The most prevalent variants within each species were selected for further analysis using in silico approaches. Accordingly, all selected GP63 proteins were antigenic and the amount of B and T cell epitopes were 23 for L. infantum , 10 for L. major , and 9 for L. tropica . The analysis of each epitope showed that all of them were non-toxic, non-allergen, and soluble but had different antigenicity values. Among these epitopes, EMEDQGSAGSAGS associated with L. major , STHDSGSTTC and AEDILTDEKRDILRK epitopes associated with L. infantum had the highest antigenicity values for B cell, MHC-I, and MHC-II epitopes, respectively. Moreover, conserved epitopes were detected among two or three Leishmania species. Conclusions/Significance This study detected many epitopes that could be used in vaccine studies and the development of serological diagnostic assays.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, ProtozoanMetalloendopeptidasesLeishmaniasis VaccinesLeishmaniasisLeishmaniaEpitopesHumansComputer SimulationEpitopes, B-LymphocyteEpitopes, T-LymphocyteLeishmania tropicaLeishmania infantumLeishmania majorProtozoan Proteins

Substanzen

glycoprotein gp63, LeishmaniaAntigens, ProtozoanMetalloendopeptidasesEpitopes, B-LymphocyteEpitopes, T-LymphocyteLeishmaniasis VaccinesEpitopesProtozoan Proteins

Autor:innen und Institutionen

  • Department of Biology Molecular Biology Section, Faculty of Science, Ege University, İzmir, Türkiye.
  • Vaccine Development, Application and Research Center, Ege University, İzmir, Türkiye.
  • Department of Vaccine Studies, Institute of Health Sciences, Ege University, İzmir, Türkiye.
  • Department of Parasitology, Faculty of Medicine, Celal Bayar University, Manisa, Türkiye.
  • Department of Parasitology, Faculty of Medicine, Ege University, İzmir, Türkiye.
  • Ödemiş Vocational School, Ege University, İzmir, Türkiye.

ORCID-Profile: Hüseyin Can

Förderung

  • The Scientific and Technological Research Council of Türkiye
  • Türkiye Bilimsel ve Teknolojik Araştırma Kurumu

Zitieren

APA

Güvendi, M., Can, H., Yavuz, İ., Özbilgin, A., Değirmenci Döşkaya, A., Karakavuk, M., Ün, C., Gürüz, A. Y., Yılmaz, İ. C., Gürsel, M., Gürsel, İ., & Döşkaya, M. (2025). In silico identification of Leishmania GP63 protein epitopes to generate a new vaccine antigen against leishmaniasis. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013137

Vancouver

Güvendi M, Can H, Yavuz İ, Özbilgin A, Değirmenci Döşkaya A, Karakavuk M, et al. In silico identification of Leishmania GP63 protein epitopes to generate a new vaccine antigen against leishmaniasis. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0013137

BibTeX
@article{Gvendi2025,
  author = {Güvendi, Mervenur and Can, Hüseyin and Yavuz, İrem and Özbilgin, Ahmet and Değirmenci Döşkaya, Aysu and Karakavuk, Muhammet and Ün, Cemal and Gürüz, Adnan Yüksel and Yılmaz, İsmail Cem and Gürsel, Mayda and Gürsel, İhsan and Döşkaya, Mert},
  title = {In silico identification of Leishmania GP63 protein epitopes to generate a new vaccine antigen against leishmaniasis},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0013137}
}
Kostenlos starten →